Keywords Type 1 diabetes Transcriptomics Beta cell decline C-peptide Disease progression Evidence before this study Type 1 diabetes is characterised by autoimmune destruction of pancreatic β-cells, but the rate of post-diagnosis decline in insulin secretion varies between individuals. Circulating C-peptide reflects β-cell function, and several studies have demonstrated heterogeneity in C-peptide decline after disease onset.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mark Peakman
Autoantigen-Specific Immunotherapies for the Prevention and Treatment of Type 1 Diabetes
2,3 1Immunology and Inflammation Research Therapeutic Area, Sanofi, Cambridge, Massachusetts 02141, USA 2Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Alberta T2N 4N1, Canada 3Institut D'Investigacions Biomèdiques August Pi i Sunyer, Barcelona 08036, Spain Correspondence: mark.peakman{at}sanofi.com; psantama{at}ucalgary.ca
Physiological and pathogenic T cell autoreactivity converge in type 1 diabetes - Nature Communications
Abstract Autoimmune diseases result from autoantigen-mediated activation of adaptive immunity; intriguingly, autoantigen-specific T cells are also present in healthy donors. An assessment of dynamic changes of this autoreactive repertoire in both health and disease is thus warranted. Here we investigate the physiological versus pathogenic autoreactive processes in the context of Type 1 diabetes (T1D) and one of its landmark autoantigens, glutamic acid decarboxylase 65 (GAD65).
Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine
1. Coppieters KT Dotta F Amirian N et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med. 2012; 209: 51-60 2. Leete P Willcox A Krogvold L et al. Differential insulitic profiles determine the extent of β-cell destruction and the age at onset of type 1 diabetes. Diabetes. 2016; 65: 1362-1369 3. Willcox A Gillespie KM Histology of type 1 diabetes pancreas. Methods Mol Biol. 2016; 1433: 105-117 4.
The challenge of modulating β-cell autoimmunity in type 1 diabetes
1. Ziegler AG Bonifacio E Powers AC Todd JA Harrison LC Atkinson MA Type 1 diabetes prevention: a goal dependent on accepting a diagnosis of an asymptomatic disease. Diabetes. 2016; 65: 3233-3239 2. Stiller CR Dupre J Gent M et al. Effects of cyclosporine in recent-onset juvenile type 1 diabetes: impact of age and duration of disease. J Pediatr. 1987; 111: 1069-1072 3. Chase HP Butler-Simon N Garg SK et al. Cyclosporine A for the treatment of new-onset insulin-dependent diabetes mellitus. Pediatrics.
Type 1 diabetes and immune-based therapies
Executive Summary Despite major advances in understanding the immunopathology of type 1 diabetes, the promise of successful immune-based therapies has so far been unfulfilled. This two-paper Series from The Lancet Diabetes & Endocrinology covers the current challenges faced in the development of immune-based therapies for type 1 diabetes and approaches to overcome them in the future.
In silico and ex vivo approaches indicate immune pressure on capsid and non-capsid regions of coxsackie B viruses in the human system
Coxsackie B Virus (CBV) infection has been linked to the aetiology of type 1 diabetes (T1D) and vaccination has been proposed as prophylaxis for disease prevention. Serum neutralising antibodies and the presence of viral protein and RNA in tissues have been common tools to examine this potential disease relationship, whilst the role of anti-CBV cytotoxic T cell responses and their targets have not been studied.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mark
Contact Mark, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack